Effects of PPARγ on hypertension, atherosclerosis, and chronic kidney disease
作者： Akira Sugawara , Akira Uruno , Masataka Kudo , Ken Matsuda , Chul Woo Yang
关键词:
摘要: … recePtor (PPAR) γ is a nuclear hormone receptor that binds to the PPAR response element (… effect, that are protective against the progression of hypertension and atherosclerosis [2]. …
ceek.jp参考文章(37)
I. Barroso, M. Gurnell, V. E. F. Crowley, M. Agostini, J. W. Schwabe, M. A. Soos, G. LI Maslen, T. D. M. Williams, H. Lewis, A. J. Schafer, V. K. K. Chatterjee, S. O'Rahilly, Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension Nature. ,vol. 402, pp. 880- 883 ,(1999) , 10.1038/47254
Hart Cm, Blanquicett C, Roman J, Thiazolidinediones as anti-cancer agents. Cancer therapy. ,vol. 6, pp. 25- 34 ,(2008)
Kazunori SATO, Akira SUGAWARA, Masataka KUDO, Akira URUNO, Sadayoshi ITO, Kazuhisa TAKEUCHI, Expression of Peroxisome Proliferator-Activated Receptor Isoform Proteins in the Rat Kidney Hypertension Research. ,vol. 27, pp. 417- 425 ,(2004) , 10.1291/HYPRES.27.417
C. Werner, C. H. Kamani, C. Gensch, M. Bohm, U. Laufs, The Peroxisome Proliferator–Activated Receptor-γ Agonist Pioglitazone Increases Number and Function of Endothelial Progenitor Cells in Patients With Coronary Artery Disease and Normal Glucose Tolerance Diabetes. ,vol. 56, pp. 2609- 2615 ,(2007) , 10.2337/DB07-0069
Jichun Yang, Dongjuan Zhang, Jing Li, Xiaoyan Zhang, Fenling Fan, Youfei Guan, Role of PPARγ in renoprotection in Type 2 diabetes: molecular mechanisms and therapeutic potential Clinical Science. ,vol. 116, pp. 17- 26 ,(2009) , 10.1042/CS20070462
Akira Sugawara, Akira Uruno, Masataka Kudo, Yukio Ikeda, Kazunori Sato, Yoshihiro Taniyama, Sadayoshi Ito, Kazuhisa Takeuchi, Transcription suppression of thromboxane receptor gene by peroxisome proliferator-activated receptor-gamma via an interaction with Sp1 in vascular smooth muscle cells. Journal of Biological Chemistry. ,vol. 277, pp. 9676- 9683 ,(2002) , 10.1074/JBC.M104560200
Akira SUGAWARA, Kazuhisa TAKEUCHI, Akira URUNO, Yukio IKEDA, Shuji ARIMA, Kazunori SATO, Masataka KUDO, Yoshihiro TANIYAMA, Sadayoshi ITO, Differential effects among thiazolidinediones on the transcription of thromboxane receptor and angiotensin II type 1 receptor genes. Hypertension Research. ,vol. 24, pp. 229- 233 ,(2001) , 10.1291/HYPRES.24.229
Michael Joner, Andrew Farb, Qi Cheng, Aloke V. Finn, Eduardo Acampado, Allen P. Burke, Kristi Skorija, Wendy Creighton, Frank D. Kolodgie, Herman K. Gold, Renu Virmani, Pioglitazone Inhibits In-Stent Restenosis in Atherosclerotic Rabbits by Targeting Transforming Growth Factor-β and MCP-1 Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 27, pp. 182- 189 ,(2007) , 10.1161/01.ATV.0000251021.28725.E8
Fabrice M. A. C Martens, Frank L. J Visseren, Eelco J. P de Koning, Ton J Rabelink, Short-term pioglitazone treatment improves vascular function irrespective of metabolic changes in patients with type 2 diabetes. Journal of Cardiovascular Pharmacology. ,vol. 46, pp. 773- 778 ,(2005) , 10.1097/01.FJC.0000187176.13403.05
P SARAFIDIS, A LASARIDIS, Actions of Peroxisome Proliferator–Activated Receptors–γ Agonists Explaining a Possible Blood Pressure–Lowering Effect American Journal of Hypertension. ,vol. 19, pp. 646- 653 ,(2006) , 10.1016/J.AMJHYPER.2005.12.017